Increasing Germline Genetic Testing for Patients With Cancer

Summary

Germline testing for hereditary cancer syndromes is underutilized across most health care settings. Using a learning health care approach, the Genomics-enabled Learning Health Systems (gLHS) network aims to evaluate the impact of a suite of implementation strategies to increase germline test ordering by oncology care teams (i.e., mainstreaming) for eligible patients with breast, pancreatic or colorectal cancer. Secondarily, the study will investigate completion of testing by eligible patients, as well as impact on overall rates of germline test ordering in patients with cancer.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Hereditary Pancreatic Cancer
• Conditions or Focus of Study
• Hereditary Breast Cancer
• Hereditary Colorectal Cancer

Eligibility basics and study details

Study type

Interventional

Phase

Not applicable

Ages

Any age

Sex

All

Healthy volunteers

Accepted

Sponsor

Josh Peterson

Last updated on ClinicalTrials.gov

June 9, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites